(143 days)
The FERR Flex™ reagent cartridge is used on the Dimension™ RxL clinical chemistry system to quantitatively measure ferritin in human serum and plasma.
The FERR Flex™ Reagent Cartridge is a one-step enzyme immunoassay based on the "sandwich" principle. Sample is incubated with chromium dioxide particles, coated with monoclonal anitbodies specific for ferritin and conjugate reagent consisting of B-galactosidase labeled monoclonal antibodies specific for a second binding site on ferritin to form a particle-ferritin-conjugate sandwich. Unbound conjugate and analyte are removed by magnetic separation and washing. The sandwich bound Bgalactosidase is combined with a chromogenic substrate chlorophenl red-b-dgalactopyranoside (CPRG). Hydrolvsis of CPRG releases a chromophore (CPR). The color change at 577 nm is directly proportional to the concentration of ferritin in the original sample.
Here's a breakdown of the acceptance criteria and study information based on the provided text:
Summary of Device Performance Study
1. Table of Acceptance Criteria and Reported Device Performance
| Performance Metric | Acceptance Criteria (Implied) | Reported Device Performance |
|---|---|---|
| Correlation Coefficient | (Not explicitly stated, but typically >0.95 for good agreement) | 0.983 |
| Slope | (Not explicitly stated, but typically close to 1) | 0.98 |
| Intercept | (Not explicitly stated, but typically close to 0) | -0.8 ng/mL |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: 60 clinical patient samples
- Data Provenance: The text states "clinical patient samples," implying human samples, but the country of origin is not specified. The study is retrospective, as it compares the new device with an existing predicate device using collected samples.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications
- This information is not provided in the text. The ground truth appears to be established by comparison to a predicate device, rather than expert consensus on individual cases.
4. Adjudication Method for the Test Set
- None directly mentioned in the context of expert review. The "adjudication" is essentially the statistical comparison (correlation, slope, intercept) between the new device and the predicate device.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
- No. This type of study is not relevant for this device, which is an in-vitro diagnostic (IVD) measurement system, not an imaging or diagnostic aid for human readers.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done
- Yes. The study evaluates the performance of the "Ferritin Flex™ Reagent Cartridge" on the "Dimension™ RxL clinical chemistry system" in a standalone manner by comparing its output to a predicate device. There is no human intervention in generating the measurement results from either device once the sample is loaded.
7. The Type of Ground Truth Used
- The ground truth (or reference standard) is the measurement obtained from the Abbott Laboratories IMx® Ferritin assay, which is the predicate device.
8. The Sample Size for the Training Set
- This information is not provided in the text. As this is an immunoassay reagent cartridge, there might not be a "training set" in the machine learning sense. The device developers would have characterized the reagent performance during R&D, but the text does not detail those internal studies.
9. How the Ground Truth for the Training Set was Established
- This information is not provided in the text. Similar to point 8, the concept of a "training set" ground truth isn't applicable in the same way as for AI/ML algorithms. The predicate device's performance would have been established through its own validation studies.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the word "DADE" in a bold, sans-serif font. The letters are large and black, contrasting with the white background. The letters are evenly spaced and aligned horizontally. The image is clear and easy to read.
DADE DITENELLI AND
Interoffice Memorandum
JAN 24 1997
Summary of Safety and Effectiveness Information
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
| Submitter's Name: | Cathy P. CraftDade International Inc.P.O. Box 6101Newark, DE 19714-6101 |
|---|---|
| Date of Preparation: | 12/03/96 |
| Name of Product: | Ferritin Flex™ Reagent Cartridge |
| FDA Classification Name: | FerritinTest System |
| Predicate Device: | Abbott Laboratories IMx® Ferritin |
Device Description: The FERR Flex™ Reagent Cartridge is a one-step enzyme immunoassay based on the "sandwich" principle. Sample is incubated with chromium dioxide particles, coated with monoclonal anitbodies specific for ferritin and conjugate reagent consisting of B-galactosidase labeled monoclonal antibodies specific for a second binding site on ferritin to form a particle-ferritin-conjugate sandwich. Unbound conjugate and analyte are removed by magnetic separation and washing. The sandwich bound Bgalactosidase is combined with a chromogenic substrate chlorophenl red-b-dgalactopyranoside (CPRG). Hydrolvsis of CPRG releases a chromophore (CPR). The color change at 577 nm is directly proportional to the concentration of ferritin in the original sample.
Intended Use: The FERR Flex™ reagent cartridge is used on the Dimension™ RxL clinical chemistry system to quantitatively measure ferritin in human serum and plasma.
{1}------------------------------------------------
Comparison to Predicate Device:
| ltem | Dimension® RxL Ferritin | Imx® Ferritin |
|---|---|---|
| Technology | Sandwich formatmonoclonal antibodyimmunoassay | Sandwich formatmonoclonal antibodyimmunoassay |
| Detection | Colorimetric ratemeasurement at 577nmand 700nm | Fluorometric endpointmeasurement |
Comments on Substantial
Equivalence: Split sample comparison between the FERR Flex™ reagent cartridge on the Dimension® RxL clinical chemistry system and the Abbott IMx® assay gave a correlation coefficient of 0.983, slope of 0.98, and an intercept of -0.8 ng/mL when tested with 60 clinical patient samples.
Conclusion: The FERR Flex™ Reagent Cartridge is substantially equivalent in principle and performance to the Imx® Ferritin Assay based on the split sample comparison discussed above.
G. "Bola
Cathy P. Craft Regulatory Affairs and Compliance Manager Date:12/03/96
§ 866.5340 Ferritin immunological test system.
(a)
Identification. A ferritin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the ferritin (an iron-storing protein) in serum and other body fluids. Measurements of ferritin aid in the diagnosis of diseases affecting iron metabolism, such as hemochromatosis (iron overload) and iron deficiency amemia.(b)
Classification. Class II (performance standards).